Dementia and Movement Disorder Treatment Market Report

China Dementia and Movement Disorder Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Sep 09, 2023
  • PAGES：212
  • REPORT CODE：GMM1783857
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Dementia and Movement Disorder Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer

    • Eisai

    • H Lundbeck

    • Amgen

    • Eli Lilly

    • Novartis

    • UCB

    • Allergan

    • F Hoffmann-La Roche

    By Type:

    • MAO inhibitors (monoamine oxidase)

    • AChE inhibitors (acetylcholinesterase)

    • Glutamate inhibitors

    By Application:

    • Branded drugs

    • Generic drugs

    • Off-label drugs

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Dementia and Movement Disorder Treatment Market Overview 2018-2029

    • 1.1 China Dementia and Movement Disorder Treatment Industry Development Overview

    • 1.2 China Dementia and Movement Disorder Treatment Industry Development History

    • 1.3 China Dementia and Movement Disorder Treatment Industry Market Size (2018-2029)

    • 1.4 China Dementia and Movement Disorder Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Dementia and Movement Disorder Treatment Production Volume, Production Value and Growth Rate of MAO inhibitors (monoamine oxidase) (2018-2029)

      • 1.4.2 China Dementia and Movement Disorder Treatment Production Volume, Production Value and Growth Rate of AChE inhibitors (acetylcholinesterase) (2018-2029)

      • 1.4.3 China Dementia and Movement Disorder Treatment Production Volume, Production Value and Growth Rate of Glutamate inhibitors (2018-2029)

    • 1.5 China Dementia and Movement Disorder Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Dementia and Movement Disorder Treatment Sales Volume, Sales Value and Growth Rate of Branded drugs (2018-2029)

      • 1.5.2 China Dementia and Movement Disorder Treatment Sales Volume, Sales Value and Growth Rate of Generic drugs (2018-2029)

      • 1.5.3 China Dementia and Movement Disorder Treatment Sales Volume, Sales Value and Growth Rate of Off-label drugs (2018-2029)

    • 1.6 China Dementia and Movement Disorder Treatment Market Analysis by Region

      • 1.6.1 North China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Dementia and Movement Disorder Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Dementia and Movement Disorder Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Dementia and Movement Disorder Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Dementia and Movement Disorder Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Dementia and Movement Disorder Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Dementia and Movement Disorder Treatment Industry Development

    Chapter 3 Dementia and Movement Disorder TreatmentIndustry Chain Analysis

    • 3.1 Dementia and Movement Disorder Treatment Industry Chain

    • 3.2 Dementia and Movement Disorder Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Dementia and Movement Disorder Treatment Market

    • 3.3 Dementia and Movement Disorder Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Dementia and Movement Disorder Treatment Market

    Chapter 4 China Dementia and Movement Disorder Treatment Market, by Type

    • 4.1 China Dementia and Movement Disorder Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Dementia and Movement Disorder Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Dementia and Movement Disorder Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Dementia and Movement Disorder Treatment Production Volume and Growth Rate of MAO inhibitors (monoamine oxidase)

      • 4.5.2 China Dementia and Movement Disorder Treatment Production Volume and Growth Rate of AChE inhibitors (acetylcholinesterase)

      • 4.5.3 China Dementia and Movement Disorder Treatment Production Volume and Growth Rate of Glutamate inhibitors

    Chapter 5 China Dementia and Movement Disorder Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Dementia and Movement Disorder Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Dementia and Movement Disorder Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Branded drugs

      • 5.5.2 China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Generic drugs

      • 5.5.3 China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Off-label drugs

    Chapter 6 China Dementia and Movement Disorder Treatment Market, by Region

    • 6.1 China Dementia and Movement Disorder Treatment Production Volume and Production Value, by Region

    • 6.2 China Dementia and Movement Disorder Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Dementia and Movement Disorder Treatment Market Analysis

    • 7.1 North China Dementia and Movement Disorder Treatment Market, by Type

    • 7.2 North China Dementia and Movement Disorder Treatment Market, by Application

    Chapter 8 Central China Dementia and Movement Disorder Treatment Market Analysis

    • 8.1 Central China Dementia and Movement Disorder Treatment Market, by Type

    • 8.2 Central China Dementia and Movement Disorder Treatment Market, by Application

    Chapter 9 South China Dementia and Movement Disorder Treatment Market Analysis

    • 9.1 South China Dementia and Movement Disorder Treatment Market, by Type

    • 9.2 South China Dementia and Movement Disorder Treatment Market, by Application

    Chapter 10 East China Dementia and Movement Disorder Treatment Market Analysis

    • 10.1 East China Dementia and Movement Disorder Treatment Market, by Type

    • 10.2 East China Dementia and Movement Disorder Treatment Market, by Application

    Chapter 11 Northeast China Dementia and Movement Disorder Treatment Market Analysis

    • 11.1 Northeast China Dementia and Movement Disorder Treatment Market, by Type

    • 11.2 Northeast China Dementia and Movement Disorder Treatment Market, by Application

    Chapter 12 Southwest China Dementia and Movement Disorder Treatment Market Analysis

    • 12.1 Southwest China Dementia and Movement Disorder Treatment Market, by Type

    • 12.2 Southwest China Dementia and Movement Disorder Treatment Market, by Application

    Chapter 13 Northwest China Dementia and Movement Disorder Treatment Market Analysis

    • 13.1 Northwest China Dementia and Movement Disorder Treatment Market, by Type

    • 13.2 Northwest China Dementia and Movement Disorder Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer

        • 14.1.1 Pfizer Company Profile

        • 14.1.2 Pfizer Dementia and Movement Disorder Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Eisai

        • 14.2.1 Eisai Company Profile

        • 14.2.2 Eisai Dementia and Movement Disorder Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 H Lundbeck

        • 14.3.1 H Lundbeck Company Profile

        • 14.3.2 H Lundbeck Dementia and Movement Disorder Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Amgen

        • 14.4.1 Amgen Company Profile

        • 14.4.2 Amgen Dementia and Movement Disorder Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Eli Lilly

        • 14.5.1 Eli Lilly Company Profile

        • 14.5.2 Eli Lilly Dementia and Movement Disorder Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Novartis

        • 14.6.1 Novartis Company Profile

        • 14.6.2 Novartis Dementia and Movement Disorder Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 UCB

        • 14.7.1 UCB Company Profile

        • 14.7.2 UCB Dementia and Movement Disorder Treatment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Allergan

        • 14.8.1 Allergan Company Profile

        • 14.8.2 Allergan Dementia and Movement Disorder Treatment Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 F Hoffmann-La Roche

        • 14.9.1 F Hoffmann-La Roche Company Profile

        • 14.9.2 F Hoffmann-La Roche Dementia and Movement Disorder Treatment Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Dementia and Movement Disorder Treatment Industry Research Conclusions

    • 15.2 Dementia and Movement Disorder Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Dementia and Movement Disorder Treatment Industry Market Size (2018-2029)

    • Figure China Dementia and Movement Disorder Treatment Production Volume, Production Value and Growth Rate of MAO inhibitors (monoamine oxidase) (2018-2029)

    • Figure China Dementia and Movement Disorder Treatment Production Volume, Production Value and Growth Rate of AChE inhibitors (acetylcholinesterase) (2018-2029)

    • Figure China Dementia and Movement Disorder Treatment Production Volume, Production Value and Growth Rate of Glutamate inhibitors (2018-2029)

    • Figure China Dementia and Movement Disorder Treatment Sales Volume, Sales Value and Growth Rate of Branded drugs (2018-2029)

    • Figure China Dementia and Movement Disorder Treatment Sales Volume, Sales Value and Growth Rate of Generic drugs (2018-2029)

    • Figure China Dementia and Movement Disorder Treatment Sales Volume, Sales Value and Growth Rate of Off-label drugs (2018-2029)

    • Figure North China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Dementia and Movement Disorder Treatment Market Size and Growth Rate from 2018-2029

    • Figure Dementia and Movement Disorder Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Dementia and Movement Disorder Treatment Market Share by Type in 2018

    • Figure China Dementia and Movement Disorder Treatment Market Share by Type in 2023

    • Figure China Dementia and Movement Disorder Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Dementia and Movement Disorder Treatment Production Volume and Growth Rate of MAO inhibitors (monoamine oxidase) (2018-2023)

    • Figure China Dementia and Movement Disorder Treatment Production Volume and Growth Rate of AChE inhibitors (acetylcholinesterase) (2018-2023)

    • Figure China Dementia and Movement Disorder Treatment Production Volume and Growth Rate of Glutamate inhibitors (2018-2023)

    • Figure China Dementia and Movement Disorder Treatment Market Share by Application in 2018

    • Figure China Dementia and Movement Disorder Treatment Market Share by Application in 2023

    • Figure China Dementia and Movement Disorder Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Branded drugs (2018-2023)

    • Figure China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Generic drugs (2018-2023)

    • Figure China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Off-label drugs (2018-2023)

    • Table China Dementia and Movement Disorder Treatment Production Volume by Region (2018-2023)

    • Table China Dementia and Movement Disorder Treatment Production Volume Share by Region (2018-2023)

    • Figure China Dementia and Movement Disorder Treatment Production Volume Share by Region (2018-2023)

    • Table China Dementia and Movement Disorder Treatment Production Value by Region (2018-2023)

    • Table China Dementia and Movement Disorder Treatment Production Value Share by Region (2018-2023)

    • Figure China Dementia and Movement Disorder Treatment Production Value Share by Region (2018-2023)

    • Table China Dementia and Movement Disorder Treatment Sales Volume by Region (2018-2023)

    • Table China Dementia and Movement Disorder Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Dementia and Movement Disorder Treatment Sales Volume Share by Region (2018-2023)

    • Table China Dementia and Movement Disorder Treatment Sales Value by Region (2018-2023)

    • Table China Dementia and Movement Disorder Treatment Sales Value Share by Region (2018-2023)

    • Figure China Dementia and Movement Disorder Treatment Sales Value Share by Region (2018-2023)

    • Table North China Dementia and Movement Disorder Treatment Production Volume by Type (2018-2023)

    • Table North China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Table North China Dementia and Movement Disorder Treatment Sales Volume by Application (2018-2023)

    • Table North China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Dementia and Movement Disorder Treatment Production Volume by Type (2018-2023)

    • Table Central China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Dementia and Movement Disorder Treatment Sales Volume by Application (2018-2023)

    • Table Central China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Dementia and Movement Disorder Treatment Production Volume by Type (2018-2023)

    • Table South China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Table South China Dementia and Movement Disorder Treatment Sales Volume by Application (2018-2023)

    • Table South China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Dementia and Movement Disorder Treatment Production Volume by Type (2018-2023)

    • Table East China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Table East China Dementia and Movement Disorder Treatment Sales Volume by Application (2018-2023)

    • Table East China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Dementia and Movement Disorder Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Dementia and Movement Disorder Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Dementia and Movement Disorder Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Dementia and Movement Disorder Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Dementia and Movement Disorder Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Dementia and Movement Disorder Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Dementia and Movement Disorder Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Dementia and Movement Disorder Treatment Sales Volume Share by Application (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Dementia and Movement Disorder Treatment Revenue, Price and Gross (2018-2023)

    • Table Eisai Company Profile

    • Table Eisai Dementia and Movement Disorder Treatment Revenue, Price and Gross (2018-2023)

    • Table H Lundbeck Company Profile

    • Table H Lundbeck Dementia and Movement Disorder Treatment Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Dementia and Movement Disorder Treatment Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Dementia and Movement Disorder Treatment Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Dementia and Movement Disorder Treatment Revenue, Price and Gross (2018-2023)

    • Table UCB Company Profile

    • Table UCB Dementia and Movement Disorder Treatment Revenue, Price and Gross (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Dementia and Movement Disorder Treatment Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Company Profile

    • Table F Hoffmann-La Roche Dementia and Movement Disorder Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US